Supplemental material, sj-docx-1-msj-10.1177_13524585221136036 for External validation of a clinical prediction model in multiple sclerosis by Nahid Moradi, Sifat Sharmin, Charles B Malpas, Vahid Shaygannejad, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Recai Turkoglu, Rana Karabudak, Nevin Shalaby, Aysun Soysal, Ayşe Altıntaş, Jihad Inshasi, Talal Al-Harbi, Raed Alroughani and Tomas Kalincik in Multiple Sclerosis Journal</p
Supplemental material, sj-docx-1-msj-10.1177_13524585221125381 for Inhibitory synaptic loss drives n...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, sj-docx-1-msj-10.1177_13524585231209016 for Inclusion of optic neuritis in di...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189674 for Intermediate outcomes for clinica...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189670 for Participant diversity in clinical...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical t...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585221139156 for Improving the decision to switch ...
Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofat...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125381 for Inhibitory synaptic loss drives n...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, sj-docx-1-msj-10.1177_13524585231209016 for Inclusion of optic neuritis in di...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189674 for Intermediate outcomes for clinica...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189670 for Participant diversity in clinical...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical t...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585221139156 for Improving the decision to switch ...
Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofat...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125381 for Inhibitory synaptic loss drives n...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, sj-docx-1-msj-10.1177_13524585231209016 for Inclusion of optic neuritis in di...